CHIEF FINANCIAL OFFICER
Kellie Seringer serves as the Chief Financial Officer of Regennabis LLC. Prior to her work with Regennabis, Kellie founded Symmetry Capital Management in 2001. At the time, Kellie was one of only 11 women in the world managing a hedge fund, growing it to roughly $400 million in assets under management (AUM).
Using this backbone of experience, Kellie implements a substantial skill set to drive change in environmental practices and social reform through impact investing. This is the core of her vision, Symmetry Capital is not only focused on outsized returns, but investment for the greater good. Her work as the CFO of Regennabis furthers this mission to help companies comply with ESG guidelines and become more sustainable.
Kellie has 25 years of public, health care equity experience. Prior to founding Symmetry Capital, she was a portfolio manager for the EGM Medical Technology Fund in 2000 and 2001. For the year 2000, the strategy was the 5th overall ranked hedge fund, as reported in January 2001 by Barron’s. Prior to EGM, she held equity research analyst positions at Evolution Capital, Montgomery Securities, now Bank of America Securities, and Dean Witter Reynolds.
Philanthropy is an important aspect to Kellie’s life. She was the President of Friends of Harvey Milk from 2010 – 2019. The Friends of Harvey Milk focuses on funding youth projects central to the mission of equity, academics and social justice in the spirit of the work and life of Harvey Milk, who dedicated his life to creating social justice and equity for all. Additionally, she has been a CASA (Court Appointed Special Advocate) in San Francisco for over 10 years and has two daughters who were formerly in foster care. Kellie has also served as the President of multiple 501(c)3 school foundations over the last decade.
Kellie graduated from Texas A&M University with Bachelor of Science degrees in Biochemistry and Genetics.